评估临床与影像生物标志物对胰腺切除术后新发糖尿病的预测价值
该回顾性队列研究纳入2006至2016年在匹兹堡大学医学中心接受胰十二指肠切除术或远端胰腺切除术的426例非糖尿病患者,分析临床与影像生物标志物对术后1年内新发糖尿病的预测价值。135/426(31.7%)患者发生新发糖尿病;多因素分析显示年龄较大、肝脂肪变性、胰腺体积减少幅度较大及术前内脏脂肪较多为独立预测因素。
要点
- 术后1年内31.7%(135/426)患者新发糖尿病。
- 肝脂肪变性(OR 1.777)、胰腺体积减少幅度大(OR 0.989)、术前内脏脂肪多(OR 1.004)及年龄较大(OR 1.02)为独立预测因素。
- 胰腺钙化、胰管直径等影像指标未显示独立预测价值。
关键影像表现/征象
- 肝脂肪变性、胰腺体积减少幅度较大及术前内脏脂肪较多与新发糖尿病独立相关。
- 胰腺钙化、胰管直径及体成分其他指标未显示独立预测价值。
诊断标准与关键数值
- 年龄:OR 1.02(95% CI 1.002-1.039,p=0.032)。
- 肝脂肪变性:OR 1.777(95% CI 1.094-2.886,p=0.02)。
- 胰腺体积减少幅度:OR 0.989(95% CI 0.979-0.999,p=0.027)。
- 术前内脏脂肪:OR 1.004(95% CI 1.001-1.006,p=0.001)。
临床应用与阅片要点
- 术前影像评估可关注肝脂肪变性、胰腺体积及内脏脂肪,辅助识别术后新发糖尿病高危患者。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
PURPOSE: To identify clinical and imaging biomarkers that can predict the new onset of diabetes mellitus (NODM) within 1 year of pancreatic resection.
METHODS: A retrospective chart review was conducted of 426 non-diabetic patients who underwent a pancreaticoduodenectomy or distal pancreatectomy at the University of Pittsburgh Medical Center between 2006 and 2016. Clinical characteristics and the patient's diabetic status at 1-year post resection were collected from the EMR. Imaging biomarkers included hepatic and pancreatic fat replacement, pancreatic calcifications, pancreatic duct diameter, pancreatic volume and body composition. Univariate and multivariable analyses were performed to demonstrate any predictive biomarkers of diabetes occurrence within 1 year of pancreatic resection.
RESULTS: 135/426 (31.7%) patients developed NODM. The only significant clinical predictor was older age (OR 1.02, 95% CI 1.002-1.039, p = 0.032). Imaging characteristics found to be significant included hepatic steatosis (OR 1.777, 95% CI 1.094-2.886, p = 0.02), larger reduction in pancreas volume (OR 0.989, 95% CI 0.979-0.999, p = 0.027), and greater preoperative visceral fat (OR 1.004, 95% CI 1.001-1.006, p = 0.001).
CONCLUSION: Age, presence of hepatic steatosis, change in pancreatic volume, and preoperative visceral fat are independent predictive biomarkers for NODM following pancreatic resection.
引用
- Donovan AL, Furlan A, Borhani AA, et al. Evaluation of clinical and imaging biomarkers for the prediction of new onset diabetes following pancreatic resection. Abdom Radiol (NY). 2021. PMID: 33474575. doi:10.1007/s00261-020-02943-3
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。